Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	894.14	977.84	1,057	1,507	2,419	552.34
Trading Asset Securities	0.08	0.08	0.08	0.12	0.52	-
Cash & Short-Term Investments	894.22	977.92	1,057	1,508	2,419	552.34
Cash Growth	20.07%	-7.45%	-29.90%	-37.68%	337.98%	8.93%
Accounts Receivable	2,514	2,542	2,249	2,046	1,460	2,487
Other Receivables	659.92	823.86	874.44	888.79	1,052	9,559
Receivables	3,174	3,366	3,123	2,935	2,512	12,046
Inventory	2,512	2,510	2,644	2,751	3,195	5,709
Prepaid Expenses	-	-	-	0	-	0.01
Other Current Assets	313.15	45.65	-14.11	190.85	158.8	234.39
Total Current Assets	6,894	6,900	6,810	7,384	8,285	18,541
Property, Plant & Equipment	3,454	3,500	3,875	4,180	4,642	9,603
Long-Term Investments	1.11	1.11	1.15	1.39	1	1
Goodwill	106.35	106.35	106.35	106.35	106.35	36.91
Other Intangible Assets	404.86	409.47	491.02	529.79	579.73	1,309
Long-Term Deferred Tax Assets	71.03	74.36	101.48	96.97	60.69	240.96
Long-Term Deferred Charges	51.08	55.05	66.47	86.71	110.22	111.57
Other Long-Term Assets	2,732	2,752	2,829	2,783	2,269	3,483
Total Assets	13,714	13,798	14,280	15,169	16,054	33,326
Accounts Payable	2,505	2,546	2,256	2,563	2,015	3,762
Accrued Expenses	49.21	520.42	716.97	1,328	1,134	2,066
Short-Term Debt	33	15.83	26.14	25.62	15.17	2,315
Current Portion of Leases	25.73	28.35	40.71	39.12	36.89	-
Current Income Taxes Payable	414.99	27.7	24.74	26.2	140.5	112.15
Current Unearned Revenue	140.22	118.82	159.89	158.12	193.85	455.19
Other Current Liabilities	2,650	2,637	2,875	1,301	1,411	14,576
Total Current Liabilities	5,818	5,894	6,100	5,442	4,947	23,286
Long-Term Debt	-	-	-	-	-	19,415
Long-Term Leases	87.91	94.95	188.16	199.13	153.22	-
Long-Term Unearned Revenue	547.64	555.78	618.68	653.98	692.97	1,035
Long-Term Deferred Tax Liabilities	24.71	26.85	51.68	55.53	-	0.05
Other Long-Term Liabilities	17.79	17.79	241.31	1,835	293.02	-
Total Liabilities	6,496	6,589	7,200	8,185	6,086	43,736
Common Stock	13,864	13,864	13,864	13,864	13,864	4,974
Additional Paid-In Capital	18,783	18,783	18,783	18,783	18,783	11,576
Retained Earnings	-24,358	-24,367	-24,375	-24,478	-21,790	-29,706
Treasury Stock	-1,107	-1,107	-1,225	-1,222	-932.82	-343.6
Comprehensive Income & Other	1.19	1.18	1.18	1.43	3.1	-3.74
Total Common Equity	7,183	7,174	7,048	6,948	9,927	-13,504
Minority Interest	35.01	34.55	32.89	35.43	41.92	126.47
Shareholders' Equity	7,218	7,209	7,080	6,984	9,968	-10,410
Total Liabilities & Equity	13,714	13,798	14,280	15,169	16,054	33,326
Total Debt	146.65	139.13	255.01	263.87	205.29	21,730
Net Cash (Debt)	747.57	838.8	801.68	1,244	2,214	-21,178
Net Cash Growth	52.95%	4.63%	-35.54%	-43.82%	-	-
Net Cash Per Share	0.05	0.06	0.08	0.09	0.16	-1.53
Filing Date Shares Outstanding	13,864	13,864	13,864	13,864	13,864	4,974
Total Common Shares Outstanding	13,864	13,864	13,864	13,864	13,864	4,974
Working Capital	1,076	1,007	709.67	1,942	3,338	-4,745
Book Value Per Share	0.52	0.52	0.51	0.50	0.72	-2.71
Tangible Book Value	6,672	6,658	6,450	6,312	9,240	-14,849
Tangible Book Value Per Share	0.48	0.48	0.47	0.46	0.67	-2.99
Buildings	-	5,119	5,229	5,401	5,665	8,359
Machinery	-	1,162	1,162	826.65	1,206	2,799
Construction In Progress	-	175.32	210.56	215.5	263.65	1,630

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.